The National Institutes of Health National Institute of Allergy and Infectious Diseases awarded multiple delivery orders against an Indefinite Delivery Contract to Advanced Bioscience Laboratories, Inc. for expertise in pediatric drug formulation development, material and data receipt/storage/shipping/inventory services, and Quality Assurance/Quality Control support. Performance will take place in Potomac, Maryland over seven years from 2023 through 2030.
The original pre-solicitation notice sought multiple contracts to provide preclinical development support services for HIV, pediatric, and prevention products, with an estimated two annual task orders each for preclinical/animal model services and bioanalytical/manufacturing support, and four task orders annually for scientific/quality services. Additionally, an initial QA/QC support task order was outlined with a one-year base period plus six one-year options requiring 0.85 full time equivalents annually. The awarded delivery orders and their associated values were: $4,145,731 for pediatric drug formulation expertise, $483,682 for material/data services, and $6,169,389 for QA/QC support. Pricing is set as cost-plus-fixed-fee for all delivery orders awarded to Advanced Bioscience Laboratories, Inc. under the Resources to Advance Pediatrics and HIV Prevention Science indefinite delivery contract.
Generated 1/4/24, 11:24 PM